What technology area does this patent fall under?

Primary CPC classification A61K31/353. Mapped technology areas include Human Necessities.

When was this patent published?

Publication date Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.

What related patents are in patentsdb?

We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).

Method for treating hepatitis C

US9301944B2 · US · B2

Patent metadata
Field	Value
Publication number	US-9301944-B2
Application number	US-201213681397-A
Country	US
Kind code	B2
Filing date	Nov 19, 2012
Priority date	Dec 30, 2008
Publication date	Apr 5, 2016
Grant date	Apr 5, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

Title
What the patent document calls the invention.
Abstract
A short plain-language summary of the technical disclosure.
Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
Key dates
Filing, priority, publication, and grant dates set the timeline.
First independent claim
The legal scope of protection — read this for what is actually claimed.
CPC / IPC classifications
Technology tags used to group this patent with similar filings.
Citations and related patents
Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure provides a method for treating hepatitis C, including: administering an effective amount of a proanthocyanidins oligomer to a subject in need, wherein the structure of the proanthocyanidins oligomer is shown as Formula (I): and in Formula (I), N is an integer of about 1-18.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for inhibiting hepatitis C viral replication, comprising: administering an effective amount of a proanthocyanidins oligomer alone to a subject in need, wherein the proanthocyanidins oligomer has inhibition activity of hepatitis C viral replication, and the structure of the proanthocyanidins oligomer is shown as Formula (I): and wherein N is an…

Assignees

Ind Tech Res Inst

Inventors

Classifications

A61K36/704
Human Necessities · mapped topic
A61K31/353Primary
Human Necessities · mapped topic
A61K36/87
Human Necessities · mapped topic
A61K2300/00
Human Necessities · mapped topic

Patent family

Related publications grouped by family.

View patent family 48572561

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Get alerts for this patent View on Google Patents

Request deeper analysis

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9301944B2 cover?: The disclosure provides a method for treating hepatitis C, including: administering an effective amount of a proanthocyanidins oligomer to a subject in need, wherein the structure of the proanthocyanidins oligomer is shown as Formula (I): and in Formula (I), N is an integer of about 1-18.
Who is the assignee on this patent?: Ind Tech Res Inst
What technology area does this patent fall under?: Primary CPC classification A61K31/353. Mapped technology areas include Human Necessities.
When was this patent published?: Publication date Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?: We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).